Abiopharma

🔍 McAlevey Michael R (Executive)

Company: HCA Healthcare, Inc. (HCA)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Sold 7,769 shares of Common Stock at $429.0 per share (Direct)
  Date: 2026-08-26 | Code: J | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | shares_owned_after: 1,084.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: By 2026 GRAT II | shares_owned_after: 7,769.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: By 2024 GRAT | shares_owned_after: 2,111.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: By managed account | shares_owned_after: 26.00 | Footnotes: F2

Footnotes:

• F1: Pursuant to a power of substitution, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $429.00 (the average of the high and low prices of shares of common stock of the Issuer on August 26, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the Reporting Person as indirectly owned. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Subsequently, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from direct ownership to a trust.
• F2: The shares reported herein are held in a fully managed account over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.